SUNPHARMA stock news on Anadi Algo News

Sunday, March 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Stock Landing|42 matching stories

SUNPHARMA Stock News, Sentiment & Trading Insights

Latest AI-analyzed news for SUNPHARMA, including sentiment, related articles, and market-moving coverage.

Top Story|livemint_markets2 days ago

Global markets entering change of eras, but India ticking boxes for FII return: Mirae's Swarup Mohanty

The Indian market is currently navigating global uncertainties, and FII flows are a critical determinant of market direction. Positive FII sentiment could provide a significant boost.

Bullish+59.490%
pharma
+59.4

Impact Score

Sectors Impacted

pharma
Maintain a bullish bias on the broader Indian market, particularly in sectors with strong earnings visibility.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
livemint_markets2 days ago

SBI share price hits four-week low as selling intensifies; m-cap slips below ₹10 lakh crore

The banking sector is currently facing headwinds from rising bond yields, which can negatively impact treasury portfolios. This, coupled with broader market sell-offs, is putting significant pressure on bank stocks.

hold
Bearish-60.390%
5 factsAXISBANK
Maintain a bearish bias on banking stocks, especially public sector banks, looking for shorting opportunities on any technical bounces. Use stop-losses diligently.|Quick check: AXISBANK bearish bias (oversold), SUNPHARMA bullish bias (overbought).
livemint_markets2 days ago

Innovision IPO Day 4: Issue booked 30% so far, price band cut to ₹494-519 apiece. GMP trades flat. Apply or not?

IPO market sentiment is influenced by subscription levels and grey market premiums. A flat GMP often suggests a listing close to the issue price.

Neutral+25.675%
5 facts
For IPOs with flat GMP, short-term listing gain opportunities are limited. Focus on the company's fundamentals for long-term investment decisions.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
et_companies2 days ago

India’s Rs 13,000 crore live events market fuelling experiential marketing push: BookMyShow–EY report

The entertainment and media sector is seeing a structural shift in consumer spending towards experiences. This trend is likely to drive revenue growth for companies catering to live events and experiential marketing.

hold
Bullish+48.185%
5 facts
Look for Indian entertainment and event management stocks with strong balance sheets and growth potential; consider a long bias with a focus on companies leveraging this experiential shift.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).

Latest SUNPHARMA Stock Coverage

et_companies3 days ago+25.6

How Today Group is shaping the next chapter of Navi Mumbai

5 factspharma
Bullish for real estate developers with strong projects in developing urban centers.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
et_economy3 days ago+33.1

India begins probe into circumvention of countervailing duty on saccharin imports

5 factspharma
Identify Indian companies that produce saccharin or its substitutes, as they could benefit from reduced competition. Companies heavily reliant on imported saccharin might face increased costs.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA bearish bias (-0.5% 1d).
livemint_markets3 days ago+8.2

Ambuja’s shift from volume chase to value accretion may take time to pay off

sell5 factsAMBUJACEMpharma
Neutral bias for Ambuja Cements in the short term; long-term positive if the strategy proves successful. Watch for execution and market acceptance of premium products.|Quick check: AMBUJACEM bearish bias (oversold), SUNPHARMA bullish bias (overbought).
et_companies3 days ago+60.2

Mukesh Ambani's Reliance capitalises on shifting energy alliances with US refinery pledge

hold5 factsRELIANCEOil & GasRefining & Marketing
Look for increased capital expenditure announcements or definitive agreements from Reliance in the refining sector, indicating further upside potential.|Quick check: RELIANCE bearish bias (-1.6% 1d), SUNPHARMA bullish bias (overbought).
et_companies3 days ago+20.6

KT Professional launches KT Men, partners MI and RCB to tap India’s men’s grooming market

5 factsConsumer GoodsPersonal Care
Consider long-term investments in established consumer goods companies with strong brand recognition and distribution networks in the personal care segment, but be mindful of increasing competition.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+13.8

Bitcoin consolidates near $70,000 as macro uncertainty offsets institutional demand

5 facts
Monitor FII/DII activity for shifts in sentiment; consider defensive sectors like pharma for stability if global macro uncertainty persists.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_companies3 days ago-50.7

Iran war exposes cracks for airlines that connect the world

5 factsAviation
Maintain a bearish bias on aviation stocks, particularly those with significant international operations, looking for shorting opportunities or reducing long positions.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+61.8

AI euphoria: How India's old economy is giving FIIs a safe hiding place

5 factsMetals & MiningCapital Goods
Monitor pharma stocks for any spillover effect from broader FII rebalancing, but the primary focus for FII inflows is currently elsewhere.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets3 days ago+47.2

Jindal Saw among 3 stocks flashing bullish signals, hinting at a possible uptrend

buy4 factsJINDALSAW
Bullish bias for Jindal Saw based on technical analysis.|Quick check: JINDALSAW bullish bias (+18.5% 1d), SUNPHARMA bullish bias (overbought).
et_companies3 days ago-24.4

India warns drugmakers against direct or surrogate weight-loss drug and obesity ads

buy5 factspharma
Neutral to slightly bearish bias for pharma companies heavily invested in the weight-loss drug segment.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy3 days ago+61.8

Eased FDI norms balance capital inflows and strategic safeguards: Experts

5 factsManufacturingCapital Goods
Look for opportunities in manufacturing and infrastructure stocks that could see increased investment and demand due to enhanced FDI inflows and supply chain integration, with a bullish bias.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy4 days ago+50.6

FDI easing not for Chinese firms; to benefit entities with minority Chinese holding

5 factsManufacturingCapital Goods
Maintain a bullish bias on pharma stocks with strong product pipelines and positive regulatory outcomes, as this FDI news is unlikely to directly impact the sector's core drivers.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_companies4 days ago-31.9

Govt cautions pharma cos against surrogate ads for promoting GLP-1 drugs

5 factspharma
Negative for pharma companies with aggressive GLP-1 marketing; consider short-term downside risk.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_markets4 days ago+5.6

Oracle shares rally 12% as strong revenue forecast eases concerns over massive AI bets

4 factspharma
No direct trade setup for Indian markets.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_companies4 days ago+50.6

India-made B28 bullet train to debut on Surat–Vapi stretch of Mumbai–Ahmedabad corridor in Aug 2027

5 factspharma
Identify companies in the railway sector, including rolling stock manufacturers, signaling companies, and civil construction firms, that stand to benefit from these projects.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy4 days ago+61.8

India to ease curbs, fast-track Chinese investment in more sectors

5 factselectronicscapital goods
Monitor companies in electronics, capital goods, and solar for potential joint ventures or increased production capacity announcements.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (-0.3% 1d).
et_economy4 days ago+59.6

India will stem the flood of Chinese imports with China's own money

5 factsManufacturingCapital Goods
Look for opportunities in manufacturing and industrial stocks, particularly those involved in components and intermediate goods, with a long-term bullish bias.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+58.1

Power sector remains a safe bet for investors amid volatility: Gautam Trivedi

5 factsPowerInformation Technology
Look for established power generation, transmission, and distribution companies with strong fundamentals; consider a long bias with a focus on dividend-yielding stocks.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_markets4 days ago+60.9

Small-cap stock HG Infra surges 20% despite stock market crash on order win. Details here

buy5 factsHGINFRAInfrastructureConstruction
Look for continued upward momentum in HG Infra, potentially targeting resistance levels, while setting tight stop-losses due to the inherent risk in small-cap stocks.|Quick check: HGINFRA neutral, SUNPHARMA bullish bias (overbought).
livemint_companies4 days ago+64.6

Adani Energy Solutions raises $500 million from Apollo Global through dollar bonds

buy5 factsADANIENSOLUtilitiesInfrastructure
Look for sustained upward momentum in ADANIENSOL, potentially driven by renewed investor confidence in the Adani Group's financial management.|Quick check: ADANIENSOL bullish bias (+4.2% 1d), SUNPHARMA bullish bias (overbought).
livemint_markets4 days ago+59.6

SEDEMAC Mechatronics share price extends gains after strong listing. Should you buy, sell or hold the stock?

buy5 factspharma
Bullish bias for SEDEMAC Mechatronics in the near term, but watch for consolidation or profit booking after the initial surge.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+37.1

Markets stay in a downtrend; sugar and pharma offer pockets of resilience: Rohit Srivastava

5 factsPharmaceuticalsSugar
Look for pharmaceutical and sugar stocks with strong balance sheets and consistent earnings, with a long-term accumulation bias.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+14.6

Bitcoin nears $70K as easing geopolitical tensions, weaker dollar lift sentiment

5 facts
Focus on company-specific news like USFDA approvals or new drug launches for pharma stocks, rather than broader crypto trends.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets4 days ago+37.1

Bitcoin nears $70K as easing geopolitical tensions, weaker dollar lift sentiment

5 facts
Monitor global risk indicators and FII flow data; a sustained positive trend in global sentiment could provide tailwinds for Indian equities, particularly large-cap indices.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_markets4 days ago+52.1

Why is IndiGo share price rising 3% despite CEO Pieter Elbers' resignation? Explained

hold5 factsINDIGOAviation
Maintain a bullish bias on aviation stocks, particularly market leaders like IndiGo, looking for entry points during minor corrections, with a stop-loss below key support levels.|Quick check: INDIGO bearish bias (oversold), SUNPHARMA bullish bias (overbought).
livemint_markets4 days ago-26.6

IndiGo share price to remain in focus today after CEO Pieter Elbers resigns

hold5 factsINDIGOpharma
Bearish bias for IndiGo in the short term due to leadership uncertainty.|Quick check: INDIGO bearish bias (oversold), SUNPHARMA bullish bias (overbought).
et_markets5 days ago+61.1

Investors turn to India as private market outpaces regional peers, McKinsey survey shows

5 factsFinancial ServicesPrivate Equity
Monitor sectors and companies that are major beneficiaries of private equity and venture capital funding for potential long-term investment opportunities.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_economy5 days ago+61.1

Cabinet clears revised cost of Rs 3,630.77 crore for developing road connectivity to Jewar airport

5 factspharma
Look for companies with a strong presence in road construction and infrastructure development in North India.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_economy5 days ago+66.5

India's exports of active pharma ingredients at Rs 41,500 cr surpassed imports in FY25

buy5 factsGRANULESpharma
Long-term bullish on Indian API manufacturers, especially those participating in the PLI scheme.|Quick check: GRANULES bullish bias (+4.0% 1d), SUNPHARMA bullish bias (overbought).
et_companies5 days ago+61.1

India's exports of active pharma ingredients at Rs 41,500 cr surpassed imports in FY25

5 factspharma
Positive for domestic API manufacturers; identify companies with strong API production capabilities and PLI scheme beneficiaries.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_companies5 days ago+38.6

Experimenting with vibe coding? Nithin Kamath says ‘If I traded and had Claude…’

hold4 factspharma
Bullish for fintech companies providing trading tools and APIs; neutral for the broader market, but indicates evolving trading patterns.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+58.7

Happiest Minds shares rocket 12% as firm raises guidance to 12.5% on AI First launch success

buy5 factsHAPPSTMNSpharma
Bullish for Happiest Minds Technologies; positive sentiment may spill over to other mid-cap IT services companies with strong AI capabilities.|Quick check: HAPPSTMNS neutral, SUNPHARMA bullish bias (overbought).
et_markets5 days ago+53.6

India gains favour with global investors on returns, ESG momentum

5 factspharma
Bullish for Indian equities, particularly companies with high ESG scores; monitor for increased FII activity.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
livemint_companies5 days ago+36.2

Inside Royal Orchid’s playbook for India’s next hotel boom

buy5 factsROHLTDpharma
Look for Royal Orchid Hotels to potentially outperform peers with its strategic expansion.|Quick check: ROHLTD neutral, SUNPHARMA bullish bias (overbought).
et_markets5 days ago+14.6

Bitcoin rebounds to $70K as easing Middle East tensions and oil price pullback lift crypto sentiment

5 factspharma
Neutral for Indian equities, but a positive indicator for global risk-on sentiment.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
et_markets5 days ago+52.1

Three decades of markets: A Balasubramanian on compounding, investor evolution and India’s long-term promise

5 factspharma
Long-term bullish bias for the broader Indian market; focus on diversified portfolios.|Quick check: SUNPHARMA bullish bias (overbought), CIPLA neutral (+0.8% 1d).
NDTV Profit5 days ago+26.9

Five Stocks To Buy: Infosys, Praj Industries, Sun Pharma, Federal Bank And DMart | March 10, 2026 - NDTV Profit

hold5 factsINFYPRAJINDSUNPHARMAbankingIT
Look for entry points in the mentioned stocks, potentially on dips, with appropriate stop-losses.|Quick check: INFY bearish bias (oversold), PRAJIND neutral (+0.8% 1d).
NDTV Profit10 days ago+41

Stock Picks Today, March 5: L&T, Coal India, Sun Pharma, India Trucking Cycle And More On Brokerages' Radar - NDTV Profit

buy4 factsCOALINDIASUNPHARMAinfrapharma
Neutral, as this is historical data. Use it to understand past market dynamics and potential long-term themes.|Quick check: COALINDIA bullish bias (+1.2% 1d), SUNPHARMA bullish bias (overbought).